(Q40322640)

English

Neutralizing antibody but not hemagglutination antibody provides accurate evaluation for protective immune response to H5N1 avian influenza virus in vaccinated rabbits

scientific article published on 7 June 2011

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Neutralizing antibody but not hemagglutination antibody provides accurate evaluation for protective immune response to H5N1 avian influenza virus in vaccinated rabbits (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

avian influenza

1 reference

based on heuristic

inferred from title

author name string

Hanping Zhu

1

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Xiaohang Ding

2

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Xuekui Chen

3

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Pingping Yao

4

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Fang Xu

5

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Ronghui Xie

6

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Zhanynv Yang

7

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Weifeng Liang

8

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Yiqing Zhang

9

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Yanjin Li

10

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Jiyou Shen

11

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Peijiang He

12

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Zhijun Guo

13

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Bo Su

14

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Shubin Sun

15

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Zhiyong Zhu

16

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

language of work or name

0 references

publication date

7 June 2011

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

33

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

5421-5423

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.067

7 January 2021

Safety, humoral and cell mediated immune responses to two formulations of an inactivated, split-virion influenza A/H5N1 vaccine in children.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.067

7 January 2021

Scientific barriers to developing vaccines against avian influenza viruses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.067

7 January 2021

Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.067

7 January 2021

Safety and immunogenicity of a subvirion inactivated influenza A/H5N1 vaccine with or without aluminum hydroxide among healthy elderly adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.067

7 January 2021

Safety and immunogenicity of an inactivated influenza A/H5N1 vaccine given with or without aluminum hydroxide to healthy adults: results of a phase I-II randomized clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.067

7 January 2021

Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.067

7 January 2021

Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.067

7 January 2021

Identifiers

10.1016/J.VACCINE.2011.05.067

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40322640&oldid=1895081128"